financetom
Business
financetom
/
Business
/
BioNTech, Duality Biologics Receive FDA Fast-Track Designation for Prostate Cancer Drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BioNTech, Duality Biologics Receive FDA Fast-Track Designation for Prostate Cancer Drug
Jun 24, 2024 5:31 AM

08:05 AM EDT, 06/24/2024 (MT Newswires) -- BioNTech (BNTX) and Duality Biologics said Monday that the US Food and Drug Administration has granted fast-track designation for their experimental drug, BNT324/DB-1311, to treat metastatic castration-resistant prostate cancer.

The designation, which facilitates the development and expedites the review of new drugs and vaccines, was based on preliminary safety and efficacy data from an ongoing phase 1/2 trial, the companies said.

Price: 86.40, Change: +1.76, Percent Change: +2.08

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rare Barbary lion cubs make their debut at Czech Zoo
Rare Barbary lion cubs make their debut at Czech Zoo
Jul 10, 2019
Roaring, pouncing and chasing each other, two Barbarylion cubs have made their public debut at a Czech Zoo, adding to a lion subspecies that has long been extinct in the wild and can only be found in captivity. The male and female cubs were born on May 10 at Dvur Kralove Safari Park and Zoo in the Czech Republic. Yet to be named, they join the park's existing Barbary lion pride that includes mum Khalila, dad Bart and his brother Napoleon. With long-haired manes, Barbary lions once inhabited the Atlas Mountains in northern Africa but have been considered extinct in the wild for decades. The last known Barbary Lion was shot in 1942 in Morocco, according to Belfast Zoo, which has its own pride of the animals, and says there are less than 90 Barbary lions living in zoos around the world.
IndiGo Promoter Dispute: If they part ways, this is the amount Rahul Bhatia has to shell out to buy out Rakesh Gangwal
IndiGo Promoter Dispute: If they part ways, this is the amount Rahul Bhatia has to shell out to buy out Rakesh Gangwal
Jul 10, 2019
A back-of-the-envelope calculation by CNBC-TV18 shows that the current market capitalisation or size of InterGlobe Aviation Ltd is Rs 53,000 crore. With this market cap, the shareholding of Rakesh Gangwal and his associates will amount to Rs 19,500-Rs 20,000 crore.
Countless lucky cats beckon at Tokyo temple
Countless lucky cats beckon at Tokyo temple
Jul 10, 2019
A large number of people visit a Buddhist temple named Gotokuji located in the Setagaya neighbourhood of Tokyo. The temple is famous for its beckoning cat figurines that are widely believed to bring good luck and prosperity to home and businesses. Some visitors come just to snap a few photos, while others make a trip to the temple to pray and make wishes.
IndiGo promoter dispute: Here are the salient points that you need to know about related party transactions
IndiGo promoter dispute: Here are the salient points that you need to know about related party transactions
Jul 10, 2019
There has been a lot of noise around related party transactions — as recent as Tuesday when differences between the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved